-
Mount Sinai, Boehringer Ingelheim to Evaluate Nintedanib for Fibrosing ILD Following COVID-19
americanpharmaceuticalreview
December 07, 2020
The Icahn School of Medicine at Mount Sinai and Boehringer Ingelheim announced the first patient has enrolled in a new clinical study to investigate the effect of nintedanib in adult patients having acute lung injury following COVID-19 infection.
-
FlowMetric Launches COVID-19 Antibody Test
americanpharmaceuticalreview
December 07, 2020
FlowMetric Life Sciences has created and brought to market a COVID-19 antibody test.
-
Baricitinib Receives EUA for Hospitalized Patients with COVID-19
americanpharmaceuticalreview
December 07, 2020
Eli Lilly and Company and Incyte announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the distribution and emergency use of baricitinib to be used in combination with remdesivir in hospitalized adult ...
-
Lilly, UnitedHealth to Study Bamlanivimab in High-risk COVID-19
contractpharma
December 07, 2020
The study will identify and treat a large, diverse population of high-risk individuals for COVID-19 with bamlanivimab under real-world conditions.
-
Zydus gets DCGI approval to commence Phase III clinical trials with Pegylated Interferon alpha-2b
expresspharma
December 07, 2020
In Phase II clinical trials, Pegylated Interferon alpha – 2b increased viral reduction and reduced the need for supplemental oxygen in moderate COVID-19 patients.
-
COVID-19 vaccination drive will commence as soon as scientists give go ahead: PM Modi
expresspharma
December 07, 2020
Healthcare workers involved in treating coronavirus patients, frontline workers and old people suffering from serious conditions would be inoculated on priority.
-
AYUSH stakeholders should focus on R&D, follow regulatory pathways: Piyush Goyal
expresspharma
December 07, 2020
He assured support to the AYUSH department to frame guidelines and standardisation processes to bring better acceptability for AYUSH products globally.
-
Career prospects in pharma in the new normal
expresspharma
December 07, 2020
The manpower needs in the pharma industry are foremost in manufacturing, quality assurance, quality control and sales, followed by other functions like HR, IT, and marketing. In this article, we’ll focus on career prospects in the top key domains of ...
-
Drawbridge Health partners with University of Cambridge Researchers for use of OneDraw? Blood Collection Device in COVID-19 and Other Clinical Studies
prnasia
December 04, 2020
Drawbridge Health and the Medical Research Council (MRC) Epidemiology Unit, University of Cambridge (UK) today announced the use of the OneDraw? Blood Collection Device1 for remote blood sample collection in a large-scale surveillance study currently ...
-
Nozin Can Help Mitigate Growing Risk of Hospital Bacterial Infections During COVID-19, Expert Suggests
prnewswire
December 04, 2020
With recent COVID-19 spikes and rise in hospitalizations, 75 percent or more of hospital infection prevention efforts can be devoted to COVID-19.